NEW YORK STOCK EXCHANGE, INC. · BIO.B
+13.73% · +$36.72 · Vol —
Bio Rad Laboratories Inc

Bio Rad Laboratories Inc

Life Sciences Tools & Services
$304.15

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is BIO.B moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Bio Rad Laboratories Inc
LABORATORY ANALYTICAL INSTRUMENTS
Founded
Listed
1900
Employees
7K
HQ
US

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$304.15
Day high
$304.15
Day low
$304.15
Previous close
$267.43
52W high
$304.15
0.00% from high
52W low
$304.15
Market cap
$7.7B
P/E
EPS
Dividend yield
Beta
Shares out
26.8M
Float
Volume
Avg volume
VWAP
Next earnings
Price history computed in-house
1W
1M
3M
1Y
YTD
SMA 50 ·
SMA 200 ·
52W position
Veridion warehouse edge

Warehouse intelligence for BIO.B.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

BIO.B insider activity

Bio Rad Laboratories Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
$0
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: $0 across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BIO.B.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

BIO.B contract awards, year to date.

Public federal awards linked to this ticker.

Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BIO.B in this window.
Lobbying spend

BIO.B lobbying filings, year to date.

Registered lobbying filings matched to Bio Rad Laboratories Inc.

$160.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Defense Medicare/Medicaid
Filing
$80.0K
BIO-RAD LABORATORIES

FORBES-TATE

Apr 17, 2026
Filing
$80.0K
BIO-RAD LABORATORIES

FORBES-TATE

Jan 18, 2026
Latest news · BIO.B
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for BIO.B.
Options
Sovereign unlock shows live options positioning for BIO.B.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.